/CMND.CN

CMND.CN Stock - Clearmind Medicine Inc.

Q: What is the analyst price target for CMND.CN?

Analyst price target information is not currently available for CMND.CN.

Q: What is CMND.CN's market cap?

Market capitalization information is not currently available for CMND.CN.

Healthcare|Biotechnology|CNQ

$1.60-12.57%

$0.23 (-12.57%) • Mar 14

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $1.76

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for CMND.CN

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

FY2022

FY2023

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.56

52W High$63.90

52W Low$1.60

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	$-77,566	$-113,379	$-2,572	N/A	N/A
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Income	$-8,501,720	$-8,532,580	$-3,676,220	$-412,909	$-105,283
Net Income	$-11,627,302	$-9,410,806	$-4,122,652	$-233,220	$-105,283
Net Margin	N/A	N/A	N/A	N/A	N/A
EPS	$-57.42	$-217.17	$-133.37	$-12.86	$-8.54

Company Overview

Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.

Visit Website